Goldman Sachs’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-399
Closed -$279K 6607
2021
Q1
$279K Buy
+399
New +$287K ﹤0.01% 5465
2015
Q1
Sell
-18
Closed -$76K 7339
2014
Q4
$76K Sell
18
-16
-47% -$92.8K ﹤0.01% 6682
2014
Q3
$290K Buy
+34
New +$293K ﹤0.01% 5787

Other funds holding MDVL

Goldman Sachs's MDVL Position: Q2 2021 in Review

Goldman Sachs sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q2 2021, closing a stake of 399 shares — an estimated $279K sold.

Goldman Sachs first reported a position in MDVL in Q3 2014 and held it in 3 quarters. The position peaked at $290K in Q3 2014. 44 funds tracked by Wall St. Rank hold MDVL as of Q2 2021.

  • Goldman Sachs reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Goldman Sachs sold 399 MedAvail Holdings, Inc. Common Stock shares in Q2 2021, an estimated $279K.
  • Goldman Sachs first reported a position in MedAvail Holdings, Inc. Common Stock in Q3 2014 and held it in 3 quarters.
  • Goldman Sachs's MedAvail Holdings, Inc. Common Stock position peaked at $290K in Q3 2014.
  • 44 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q2 2021.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.